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Objectives: This study examine dose-response relationships of walking with multiple 
aspects of physical function and measures of body fatness in apparently healthy, 
independent adults aged 50-80 years. 
Methods:  201 adults (81 male, 120 female) aged 50-80 years underwent 
assessment of body mass index (BMI), Body fatness, waist circumference (WC) and 
6 measures of functional fitness. Sealed pedometery, worn over 7 days, was used to 
determine physical activity (PA). PA was categorized into 3 groups (low=2501-5000, 
medium=5001-7500, and high=>7501 steps/day). 
Results: Results from a series of 2 (gender) X 3 (PA dose) ways analysis of 
covariance (ANCOVA), controlling for age indicated dose-response effects of PA for 
all functional fitness tests where participants classed as High PA had higher scores 
for arm curl, chair stand, 6 minute walk, back scratch and sit and reach and lower 
scores for timed up and go test compared to those classed as Low and Medium PA. 
There were also significant main effects for PA dose for BMI, WC, and body fat %. 
Those classed as low PA had significantly higher BMI, WC and body fatness 
compared to those classed as medium and high PA.  
Conclusions: This study shows a positive dose-response trend whereby as an 
individual undertakes more daily steps (based on previously established step-count 
groups), multiple aspects of functionality increase and anthropometric markers of 
overweight and obesity decrease. 
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Introduction 
The world population is becoming increasing older (United Nations, 2005) and 
such a large scale demographic has far reaching implications for public health and 
quality of life in older adulthood (Reinhardt, 2003). Understanding how health 
enhancing behaviours impact on physical function and body fatness is an important 
first step in establishing effective preventive measures to enhance older adults’ 
health. 
Age related loss of muscle mass and strength, termed sarcopenia, has been 
cited as one of the key public health issues in the older adult population as it results 
in reduced mobility, loss of independence, higher risk of falls and reduced quality of 
life (Montero-Fernandez et al., 2013). Age related loss of muscle mass is 
compounded by age related infiltration of fat into muscle which also leads to loss of 
physical function (Visser et al., 2005) and increased body fatness is associated with 
decreased physical function as age increases (Bouchard et al., 2009). As a 
consequence, understanding effective means to offset sarcopenia, reduce 
overfatness and cost effective means to maintain health and offset age-related 
declines in physical function are a public health priority.  
Participation in physical activity (PA) has protective effects on multiple facets 
of health in older adults including cardiovascular disease and its related 
comorbidities (Luuk and Pihl, 2003), age-related cognitive decline (Kramer, et al., 
1999), functional limitation (Bouchard, et al., 2011) and body fatness (Bouchard, et 
al., 2011). However, estimates suggest that only 20% of the older adult population 
are sufficiently active for health benefits (Hansen et al., 2012; Metzger et al., 2008) 
and that the average amount of moderate to vigorous physical activity decreases at 
a rate of 1 minute/day between the ages 65-85 (Hansen et al., 2008). 
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Walking is the most common form of activity/exercise in older adults, despite 
the decreases in physical activity seen with increasing age, as it is readily available 
and can be engaged in as part of everyday life (Sherwood and Jeffery, 2000). 
Despite this, there is uncertainty regarding the beneficial relationships of walking 
volume on physical functioning, especially when evaluating the impact of dose 
(increasing walking volume) – response (changes in physical functioning) in older 
populations (Dondzila et al., 2015). Recently, Dondzila et al (2015) demonstrated a 
dose-response relationship with walking volume and self-reported physical function 
and 6 minute walk test (6MWT) performance in a sample of American older adults. In 
their study, there was a graded relationship whereby high PA was associated 
increased 6MWT distance and self-reported physical functioning. The present study 
sought to act on the subsequent recommendations of Dondzila et al (2015) by 
investigating whether such dose-response relationships exist with other aspects of 
functionality and anthropometric measures in a sample of older adults. Furthermore, 
while most prior work has tended to focus on adults aged 60 years or older, the 
present study examined adults aged 50-80 years. This was purposeful as 
comparatively little is known about time course and transition to sarcopenia (Murphy 
et al., 2013) and age related changes in muscle mass, strength and performance is 
said to occur form 50 years of age (Lindle et al., 1997, Lynch et al., 1999, Janssen et 
al., 2000). Understanding changes in physical functioning from this age onwards 
may have significance in terms of older adult quality of life (Lynch et al., 1999) and 
the decade 50-60 may be an important window for the development of effective 
interventions to ameliorate changes in physical functioning as a consequence of 
ageing in older adulthood (Lindle et al., 1997, Lynch et al., 1999, Janssen et al., 
2000). The aim of this study was to examine dose-response relationships of walking 
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with multiple aspects of physical function and measures of body fatness in 
apparently healthy, independent adults aged 50-80 years. 
 
METHODS 
Participants 
Following institutional ethics approval and written informed consent, 201 
independent, community-dwelling adults aged 50-80 years (81 male, 120 female, 
mean age ± SD = 66.1 ± 7.7 years) were recruited from local community groups 
within the city of Coventry, UK in 2015. Prior to participation, each participant 
completed a health history questionnaire to record past and present health 
conditions. Exclusion criteria were the following: registered blindness, severe hearing 
impairment uncontrolled hypertension or diabetes, symptomatic cardiorespiratory 
disease, severe renal or hepatic disease, uncontrolled epilepsy, progressive 
neurological disease, chronic disabling arthritis or any musculoskeletal condition 
which prohibited physical activity/exercise. Participants who were currently taking 
beta blockers of calcium ion channel blockers were also excluded from taking part.  
 
Procedures 
 
 
Anthropometric Measures and Body Fatness 
Body mass, measured to the nearest 0.1kg and height, to the nearest 1mm 
were assessed barefoot with participants wearing light clothing using a Seca 
Stadiometre and Weighing scales (Seca Instruments, Germany, Ltd). Body mass 
index (BMI) was then determined as kg/m2. Waist circumference (WC, cm) was 
assessed using an anthropometric measuring tape at the level of the umbilicus at the 
end of gentle expiration. Body fatness (%Fat) was determined using leg to leg 
6 
 
bioelectrical impedance analysis (Tanita BF-350, Tanita Inc, Japan). Participants 
adhered to recommended guidelines for accurate assessment of body fatness using 
bioelectrical impedance analysis including no drinking for 4 hours prior to the test, no 
exercise for 12 hours prior to the test, urination 30minutes prior to the test, and no 
alcohol consumption for 48hours before the test (Heyward, 1991). 
 
 
Assessment of Physical Function 
Physical Function was assessed using Rikli and Jones (1999) Senior Fitness 
Test, comprising the:  6MWT, 8Foot Timed Up and Go (TUG), Arm Curl (AC), Chair 
Stand (CS), Back Scratch (BS) and Chair Sit and Reach (SAR) test. All procedures 
followed those described previously for administration of the Senior Fitness Test 
(Rikli and Jones, 2001). The TUG comprised the number of seconds required to get 
up from a seated position, walk 8 feet, turn, and return to seated position. For AC the 
number of bicep curls that were completed in 30 seconds holding a hand weight of 
2.27kg for females and 3.63kg for males was recorded. The CS test comprised the 
number of full stands that could be completed, from a seated position, in 30 seconds 
with arms folded across the chest. The BS tests was completed for both the right and 
left sides where one hand reached over the shoulder with the other up the middle of 
the back. Distance (cms) between extended middle fingers was assessed and the 
average of right and left sides was taken as an overall measure. The SAR was 
completed from a sitting position at the front of a chair with one leg extended and 
hands reaching towards toes with the distance (cms) between extended fingers and 
tip of toe being assessed. The average of right and left sides was taken as an overall 
measure of flexibility. For the 6MWT participants were instructed to walk as quickly 
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as possible for 6 minutes up a down a 20m walkway marked off in 2m segments, 
and were informed that they could slow down or rest if necessary. Standardised 
encouragement was given each minute during the tests. The distance walked was 
recorded and used for analysis. 
 
Assessment of Habitual Physical Activity 
Habitual physical Activity (PA) was determined using a sealed, piezo-electric 
pedometer (New Lifestyles, NL2000, Montana, USA) worn over seven days. Prior to 
the monitoring period, participants were familiarized with the pedometers and were 
briefed as to the nature of their involvement in the study. During familiarisation, the 
participants were instructed on pedometer attachment (at the waist), its removal 
(only during showering/bathing, swimming or sleeping), and reattachment on waking 
each morning. Participants were asked not to tamper with the pedometer and to go 
about their normal activities during the monitoring period. The model of pedometer 
employed in the study shows good validity and has been found to be highly accurate 
(Crouter, Schneider, & Bassett, 2005). Daily step counts were stored in the internal 
memory of each pedometer enabling recall of each day’s step count on collection of 
each pedometer. Across the period of measurement, the participants were asked to 
complete a pedometer log to verify that the pedometers were worn for the entire time 
of the study. The average steps/day values was then segmented into four groups to 
characterise walking behaviour; < 2500steps/day, 2501-5000 steps/day, 5001-7500 
steps/day and >7500 steps/day, as used by Donzila et al (2015) when examining the 
dose-response of walking behaviour with 6MWT distance in older adults. However, 
in the current study no participants recorded average daily step counts of <2500 
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steps/day, leaving data characterised into 3 groups: low PA (2501-5000 steps/day), 
medium PA (5001-7500 steps/day) and high PA (>7500 steps/day). 
 
Statistical analysis 
Data were analysed using the Statistical Package for Social Sciences Version 
20 (SPSS Inc., Chicago, IL, USA) and the alpha level was set at p < 0.05 a priori. A 
series of Analysis of Covariance (ANCOVAs) were used to examine any dose-
response effect of walking PA on BMI, WC, %Fat and measures of physical function. 
Gender and PA category (low, medium, high) were used as between subjects factors 
and age was employed as a covariate. In this way the analysis was able to 
determine any effect of gender and PA category on the dependant variables in 
question whilst at the same time explaining the amount of variance explained for 
each dependant variable by the covariate of age (Field, 2010).  Partial η2 was also 
used as a measure of effect size. In all cases backwards elimination to achieve a 
parsimonious solution was employed. 
 
Results 
 
Anthropometric Variables 
Mean ± SE of anthropometric variables split by gender and PA dose are 
presented in Table 1. Results from ANCOVAs, controlling for age indicated 
significant gender main effects for gender for BMI (P = 0.0001, Partial η2 = .075), WC 
(P = 0.0001, Partial η2 = .278) and body fat % (P = 0.011, Partial η2 = .04). Males 
had higher values for BMI and WC but lower values for body fatness % compared to 
females. There were also significant main effects for PA dose for BMI (P = 0.0001, 
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Partial η2 = 0.179), WC (P = 0.0001, Partial η2 = 0.147), and body fat % (P = 0.0001, 
Partial η2 = 0.201).  In all cases, those classed as low PA had significantly higher 
BMI, WC and body fatness compared to those classed as medium and high PA (all P 
= 0.01 or better). There were no gender X PA dose interactions and nor was age 
significant as a covariate for any of the anthropometric variables (P>0.05).  
 
Physical Function and Physical Activity 
Mean ± SE of functional fitness variables split by gender are presented in Table 2. 
ANCOVA identified significant gender main effects for BS (P = 0.015, Partial η2 = 
0.036) and SAR (P = 0.001, Partial η2 = 0.151) tests, in all cases females performed 
significantly better than males. In regard to PA dose, significant main effects were 
evident for CS (P = 0.001, Partial η2 = 0.095), AC (P = 0.001, Partial η2 = 0.168), 
TUG (P = 0.001, Partial η2 = 0.095), 6MWT (P = 0.001, Partial η2 = 0.375), BS (P = 
0.001, Partial η2 = 0.173), and SAR (P = 0.001, Partial η2 = 0.190).  
 For all tests other than CS there were significantly poorer values for each test 
between those classed as low PA and medium PA, low PA and high PA, and 
medium PA and high PA (all P>0.05 or better). For CS there were significantly 
poorer scores for those classed as low PA compared to high PA (P = 0.002) and 
those classed as medium PA compared to high PA (both P = 0.001). There was no 
significant difference in CS scores between those classed as Low PA and medium 
PA (P = 1.0). Age was significant as a covariate for 6MWT (P = 0.001, β = -2.559) 
but not for CS, AC, TUG, BS or SAR (P >0.05). This indicated that every 1 year 
increase in chronological age was associated with decrease of 2.5 metres walked in 
the 6MWT.  In regard to pedometer determined PA, the mean steps/day ± SE 
undertaken by participants in the current study was 7052.2 ± 204.2. When split by 
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PA dose the mean steps/day ± SE was 4119 ± 118.1, 6307 ± 118.6 and 7475 ± 
201.1 steps/day for low, medium and high PA groups. 
 
Discussion 
Although walking is the most common form of PA that older adults engage in, 
previous research has been equivocal as to the potential protective benefits of 
walking towards physical function as one progressively attains more steps (Dondzila 
et al., 2015). The results of the current study show a clear and positive dose-
response trend whereby as an individual undertakes more daily steps (based on 
previously established step-count groups), multiple aspects of functionality increase 
and anthropometric markers of overweight and obesity decrease. It is key to note 
that every aspect of physical function that was assessed in the present study 
showed some form of dose-response where increased PA resulted in improved 
function.  These results extend recent work by Dondzila et al (2015) which reported a 
dose-response effect of walking for the 6MWT and self-report function in a sample of 
over 800 older adults. It is also the first to demonstrate such effects in British adults 
aged 50 years and older. The results of the present study are also supportive of prior 
work that has shown that increases in walking volume are positively related to 
numerous health outcomes including body mass index (Tudor-Locke et al., 2008), 
metabolic syndrome (Park et al., 2008) and quality of life (Yasunga et al., 2006). 
Moreover, a number of studies have identified increased PA to be associated with 
6MWT in older, diseased, adults (Mudge and Stott, 2009). 
The population recruited in the present study were apparently healthy, mobile 
and functionally able and were not selected as representative of the overall older 
adult population. Rather, this study sought to examine the effect of healthy active 
11 
 
ageing who were aged 50-80 years. This decision is congruent with prior work that 
has sought to examine active ageing (Skelton et al., 1994) as it is important to be 
able to assess and identify and measure factors limiting functional ability in ageing in 
those individuals who are apparently healthy and mobile. Given the 
inclusion/exclusion criteria employed in the present study, the participants might be 
considered in good health and ‘active’ and, as such, indicative of what might be 
expected in an ageing population who are free from any form of hypokinetic disease. 
Indeed, the mean scores for all of all the physical function tests employed in the 
present study sat within the 50-60th age and gender specific percentiles as reported 
by Rikli and Jones (1999).  The dose-response responses identified in this study 
could therefore only be considered representative of an active population. It is 
however important to establish that such a dose-response exists in a healthy and 
mobile adult population as a first step to targeting preventive efforts in individuals 
who are physically able to increase their habitual PA. A useful next step would be to 
establish whether such a dose-response exists in individuals with very low levels of 
habitual PA (<2500 steps/day). When physical function tests are considered across 
low and high PA groups, participants classified as low PA scored in the 10th 
percentile for 6MWT, BS, SAR and TUG tests and the 25th percentile for AC and CS 
tests. Conversely those classed as high PA scored between the 75th and 90th 
percentile for the AC, CS and 6MWT, between the 50th and 75th percentile for SAR, 
BS and TUG tests based on gender and age specific norms previously reported 
(Rikli and Jones, 1999).  
 The present study also recruited individuals from the age of 50 to 80 years on 
the basis that understanding any changes in physical function from the age of 50 is 
important in developing effective interventions to enhance physical function with age 
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(Lindle et al., 1997, Lynch et al., 1999, Janssen et al., 2000). Despite this, few 
studies have examined the association between objectively assessed walking 
behaviour and physical function in adults from the age of 50 onwards.  
In the current study walking behaviour was grouped using the same method 
employed by Dondzila et al, which was based on data suggesting that ambulatory 
estimates for healthy older adults approximate 2000-9000 steps/day (Tudor-Locke, 
et al., 2011). In the current study the mean steps/day was 7052.2. Consequently, the 
PA levels of participants in the present study are greater than those reported by 
Dondzila et al (2015). This is not surprising given the different age ranges used in 
the present study compared to that of Dondzila et al (2015). It is also important to 
note that there was a significant relationships between age and average steps/day (r 
= -.574, P = .001) in the present study as well as a significant decade by decade 
decrease in average steps/day (P =.001). Mean steps/day ± SE was 9247 ± 317.6, 
7537 ± 257.7 and 6016 ± 296.6 for adults aged 50-59, 60-69 and 70-80 years 
respectively. 
Overall, however, the results of the present study might suggest that in strictly 
healthy and mobile adults aged 50-80 years, decreases in functional performance 
and increases in fatness may be deferred to an older age and that these positive 
changes are amplified where habitual physical activity is greater. 
There are however some limitations to this study. The cross-sectional design 
employed makes it difficult to discern causality of PA effects on physical functions. 
There were also fewer participants in the ‘low’ PA group in the current study 
compared to the medium and high PA groups. Moreover, pedometry might be 
considered a limitation in terms of PA assessment as it cannot differentiate mode or 
intensity of PA. However, pedometers are cost effective tools which accurately 
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capture ambulatory activity. They also offer a methodology which older adults appear 
to feel more at ease with in terms of procedure engagement and subsequent 
understanding of the meaning of any PA results obtained. This is important in terms 
of maximising impact and ensuring clear public health messages from any study of 
dose-response of PA on health parameters. Without trying to exaggerate the impact 
of the results presented here, the current study is important for public health in 
demonstrating the strength of dose-response relationships between ambulatory 
activity and measures of physical function.  The key public health message arising 
from the current study is that a minimum threshold of 7500 steps/day should be 
recommended for maintenance of physical function in healthy, independent adults 
aged 5-80 years and that increases in ambulatory PA above this level will likely 
result in greater benefit in physical function.  
Given the inclusion and exclusion criteria employed in the present study, the 
results presented here are only indicative of healthy, active adults aged 50-80 years. 
It may therefore be useful for future research to examine dose-response effects of 
PA on multiple aspects of physical function in both healthy and diseased older adult 
populations. 
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Figure 1. Mean ± SE of scores for a) chair stand, b) arm curl, c)8 foot timed up and go, d)six minute 
walk, e)back scratch and f)chair sit and reach tests in healthy adults aged 50-80 years (*P = 0.01). 
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Table 1. Mean ± SE of Body Mass Index (BMI), Waist Circumference (WC) and Body fat percentage between males and females and 
participants classified as low, medium or high habitual physical activity (PA). Coventry, UK, 2015.* P = 0.0001, ** P = 0.011, a P = 0.002 
between low and medium PA, b P = 0.001 between low and high PA, c P = 0.001 between medium and high PA, d P = 0.009 between low and 
medium PA, e P = 0.002 between medium and high PA, f P = 0.002 between medium and high PA 
 Gender PA Dose 
 Male (n = 81) Female (n = 120) Low (n = 35) Medium (n = 75) High (n = 91) 
BMI (kg/m2) 28.6 (.53)* 26.6 (.35) 30.2 (.812)a, b 27.4 (.437)c 24.5 (.429) 
WC (cm) 99.1 (1.1)* 86.6 (.93) 98.8 (1.78)b, d 92.8 (1.1)e 86.9 (1.1) 
Body Fat (%) 30.3 (.76)** 32.8 (.63) 36.3 (1.22)b, f 31.6 (.78)c 26.7 (.750) 
ANCOVA, controlling for age. 
  
Table 2. Mean ± SE of functional fitness test values between males and females and participants classified as low, medium or high habitual 
physical activity (PA). Coventry, UK, 2015. * P = 0.015, ** P = 0.001, a P = 0.002 between low and high PA, b P = 0.001 between medium and 
high PA, c P =0.01 between low and medium PA, d P = 0.001 between low and high PA, e P = 0.001 between medium and high PA, f, g P = 
0.001 between low and medium and low and high PA, h P = 0.001 between medium and high PA, I P = 0.004 between medium and high PA, j P 
= 0.015 between medium and high PA. 
 Gender PA Dose 
 Male (n = 81) Female (n = 120) Low  
(2501-5000 
steps/day) 
  (n = 35) 
Medium  
(5001-7500 
steps/day) 
 (n = 75) 
High  
(>7500 steps/day) 
(n = 91) 
Chair Stand (no/30 secs) 14.7 (.51)** 14.9 (.43) 13.3 (.81)a 14.4 (.52)b 16.9 (.51) 
Arm Curl (no/30 secs) 15.9 (.42)** 16.1 (.35) 13.7 (.61)c, d 15.8 (.43)e 18.4 (.41) 
8 Foot Timed Up and Go (secs) 6.1 (.11)** 5.9 (.09) 7.3 (.17)f, g 5.8 (.11)h 5.1 (.11) 
6 minute walk test (metres) 512.6 (8.4)** 503.2 (6.9) 445.2 (13.4)f, g 506.1 (8.5)h 572.6 (8.2) 
Back Scratch (cms) -7.7 (.94)* -4.9 (.78) -12.1 (1.5)f, g -5.7 (.97)i -1.2 (.93) 
Chair Sit and Reach (cms) -4.4 (.95)** 2.0 (.79) -7.7 (1.5) f, g 0.8 (.96) j 4.2 (.96) 
ANCOVA, controlling for age. 
 
   
 
